Controversies in Mediastinal Staging of Peripheral Lung Nodules: Should We Perform EBUS at All?

Session Format

Live Webinar

Session Type

Clinical Controversy

Topic Area

Lung Cancer

Session Date

October 21, 2020 8:45 AM - 9:45 AM

Description

The question of when to pursue invasive mediastinal staging with EBUS in the setting of a negative nodal evaluation by PET has been a frequent topic of debate. There is no clear consensus between ACCP, ERS, and NCCN guidelines on this topic. ACCP guidelines, suggests that peripherally located radiographic stage 1A disease (ie, less than 3 cm) should not require EBUS staging. A recent publication in 2017 suggests that nodal metastatic disease for peripheral T1aN0 NSCLCa is not negligible. In this Pro-Con debate, we present two well-known experts debating the utility of EBUS in all these scenarios.

Learning Objective 1

Summarize ACCP, ERS, and NCCN guidelines regarding invasive mediastinal staging for peripheral lung nodules.

Learning Objective 2

To discuss the value and role of EBUS (pro and cons) in peripheral lung nodules.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	1 CME Credit